Sign in

STEK on OTC

Stemtech Corp

Stemtech Corp is a wholesale-drugs company, listed on OTC (STEK).1 It is headquartered in Naples, Florida.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Can B Corp, HWH International Inc. or Cellyan Biotechnology Co., Ltd, or pick any stock.

  • TickerSTEK on OTC1
  • IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries1
  • HeadquartersNaples, Florida1
  • Business address4851 Tamiami Trail North, Suite 200, Naples, Fl 341032
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

80.3%Gross margin3
-94.2%Operating margin3
-140.7%Net margin4
-43.1%Revenue growth, 20253
-$483.6KFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Regions

Latin America brought in 53% of the revenue Stemtech Corp broke down this way in fiscal 2025.

  1. Latin America$1.5M353%down 43% from 2024
  2. Americas$1.2M343%down 43% from 2024
  3. Asia$116.9K34%down 46% from 2024
Regions by year
Regions20242025
Latin America$2.7M$1.5M
Americas$2.2M$1.2M
Asia$215.3K$116.9K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue20¢$566.9K
  • Other costs80¢$2.3M

Out of $2.9M in revenue.34 The company lost money this year.

Financial statements

Revenue56783$2.9M in 2025−34% since 2020
0$2.0M$4.0M$6.0M2020: $4.4M$4.4M20202021: $4.3M$4.3M2021−1%2022: $4.6M$4.6M2022+6%2023: $4.9M$4.9M2023+8%2024: $5.1M$5.1M2024+3%2025: $2.9M$2.9M2025−43%
Gross profit56783$2.3M in 2025−37% since 2020
0$1.0M$2.0M$3.0M$4.0M2020: $3.7M$3.7M20202021: $3.3M$3.3M2021−10%2022: $3.4M$3.4M2022+3%2023: $3.9M$3.9M2023+15%2024: $3.7M$3.7M2024−5%2025: $2.3M$2.3M2025−38%
Operating income956783-$2.7M in 2025+13344% since 2019
-$6.0M-$4.0M-$2.0M02019: -$20.1K-$20.1K20192020: -$1.4M-$1.4M2020+7006%2021: -$3.2M-$3.2M2021+124%2022: -$5.0M-$5.0M2022+56%2023: -$4.2M-$4.2M2023−16%2024: -$2.4M-$2.4M2024−44%2025: -$2.7M-$2.7M2025+14%
Net income95674-$4.0M in 2025+11863% since 2019
-$10.0M-$7.5M-$5.0M-$2.5M02019: -$33.8K-$33.8K20192020: -$916.7K-$916.7K2020+2610%2021: -$7.1M-$7.1M2021+672%2022: -$8.5M-$8.5M2022+21%2023: -$5.4M-$5.4M2023−36%2024: -$3.8M-$3.8M2024−31%2025: -$4.0M-$4.0M2025+7%

Every line of the income statement as filed: the last 3 fiscal years, latest first.3

Period ending2025-12-312024-12-312023-12-31
NET SALES$2.9M$5.1M
Cost of goods sold$496.8K$1.2M
Freight-in$70.1K$109.9K
TOTAL COST OF GOODS SOLD$566.9K$1.3M
GROSS PROFIT$2.3M$3.7M
Commissions$437.0K$780.8K
Selling and marketing$27.2K$99.2K
General and administrative$4.6M$5.2M
Research and development$0$0
TOTAL OPERATING EXPENSES$5.0M$6.1M
OPERATING LOSS-$2.7M-$2.4M
Change in fair value of derivative liability$0$0
Interest expense-$1.5M-$1.6M
Other income and expenses, net$111.4K$85.4K
Gain on settlement of derivative liabilities$0$0
Gain (loss) on extinguishment of debt$0$107.7K
Loss on disposal of assets$0$0
TOTAL OTHER INCOME (EXPENSE)-$1.3M-$1.4M
INCOME (LOSS) BEFORE INCOME TAXES-$4.0M-$3.8M
PROVISION FOR INCOME TAXES$0$0
NET LOSS-$4.0M-$3.8M
NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS-$3.1K-$3.1K-$1.7K
Basic-$0.02-$0.03
Diluted-$0.02-$0.03
Basic169.8M shares118.7M shares
Diluted169.8M shares118.7M shares
Net loss-$4.0M-$3.8M-$5.4M
Change in foreign currency translation adjustments$6.5K-$336.8K
Comprehensive loss available to common stockholders-$4.0M-$4.1M

Compare Stemtech Corp with another company

Corporate structure

Stemtech Corp sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Stemtech Corp

  • Stemtech Corp Naples, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Stemtech Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$03 Dec 31, 2024$10.1K8 Dec 31, 2023−100.0%
Operating-lease assets (leased space)$03 Dec 31, 2025$03 Dec 31, 2024

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$467.4K3 Dec 31, 2025$467.4K3 Dec 31, 20240%
Intangible assets, net (excluding goodwill)$2.2M3 Dec 31, 2025$2.4M3 Dec 31, 2024−7.0%
Accumulated amortization-$3.0M3 Dec 31, 2025-$2.8M3 Dec 31, 2024−5.9%
Finite-lived intangibles, net$2.2M3 Dec 31, 2025$2.3M8 Dec 31, 2024−7.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$217.3K3 Dec 31, 2025$197.4K3 Dec 31, 2024+10.1%
Finished goods$217.3K3 Dec 31, 2025$197.4K3 Dec 31, 2024+10.1%

Leadership

Who has led Stemtech Corp, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Former names

  • Globe Net Wireless Corp.Feb 11, 2011 to Sep 21, 20212

Timeline

  1. Apr 14, 20258-K Executive or director change13
  2. Jan 3, 20258-K Regulation FD disclosure14
  3. Dec 6, 20248-K Entered a material agreement; Regulation FD disclosure15
  4. Dec 3, 20248-K Entered a material agreement16
  5. Aug 19, 20248-K Change of auditor17
  6. Mar 31, 20238-K Entered a material agreement18
  7. Apr 18, 20228-K Bylaws or fiscal year changed19
  8. Nov 12, 20218-K Bylaws or fiscal year changed20
  9. Nov 12, 20218-K Change of auditor21

Filings

65 filings to the SEC since October 2021: 5 annual reports, 18 quarterly reports, 9 major events, 9 insider forms, 2 large holders, 22 other. The latest 20:

  1. Aug 14, 202610-Q FORM 10-Q FOR JUN 2026 EDGAR
  2. Jun 22, 202610-Q QUARTERLY REPORT EDGAR
  3. May 29, 202610-K FORM 10-K FOR DEC 2025 EDGAR
  4. May 14, 2026NT 10-Q/A AMENDMENT NO 1 EDGAR
  5. May 14, 2026NT 10-Q NOTICE OF LATE FILING EDGAR
  6. Mar 31, 2026NT 10-K EXTENSION FOR DECEMBER 2025 10-K EDGAR
  7. Nov 19, 202510-Q FORM 10-Q FOR SEP 2025 EDGAR
  8. Nov 14, 2025NT 10-Q 09-30-25 10-Q EXTENSION EDGAR
  9. Aug 19, 202510-Q FORM 10-Q FOR JUN 2025 EDGAR
  10. Aug 14, 2025NT 10-Q EXTENSION EDGAR
  11. Jul 17, 202510-Q FORM 10-Q FOR MAR 2025 EDGAR
  12. Jun 30, 202510-K FORM 10-K FOR DEC 2024 EDGAR
  13. Jun 27, 20254 PRIMARY DOCUMENT EDGAR
  14. May 15, 2025NT 10-Q/A AMENDED EXTENSION REQUEST EDGAR
  15. May 15, 2025NT 10-Q 10-Q EXTENSION EDGAR
  16. Apr 14, 20258-K STEMTECH EDGAR
  17. Mar 31, 2025NT 10-K EXTENSION EDGAR
  18. Jan 3, 20258-K CURRENT REPORT EDGAR
  19. Dec 6, 20248-K CURRENT REPORT EDGAR
  20. Dec 3, 20248-K CURRENT REPORT EDGAR

The 65 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 1 buys and 2 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 23, 2025KAPLAN BENJAMIN NATHANIELDirectorSale1,000,000$0.03$30.0KForm 4
Jul 26, 2024ARNOLD CHARLES STUARTDirectorBuy25,000$0.05$1.2KForm 4
Apr 19, 2024Mindshare Holdings, Inc.Sale25,000$0.06$1.5KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Stemtech Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARStemtech Corp1
  • CIK0001511820
  • Employer ID (EIN)87-215144024
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company24
  • Incorporated inNevada24
  • Fiscal year endsDecember 311
  • Industry code (SIC)5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address4851 Tamiami Trail North, Suite 200, Naples, FL 341031
  • Phone(954) 715-60001
  • Shares outstanding2,997,032,856 as of Aug 13, 20264
  • Public float$5.6M as of Jun 30, 202524
  • AuditorBush & Associates CPA LLC, Las Vegas, Nevada PCAOB ID 6797; no auditor attestation of internal control over financial reporting24
  • On EDGAR sinceFeb 11, 20111
  • Filings159 in all: 10-Q (39), 8-K (18), NT 10-Q (17), S-1/A (15), 10-K (13), CORRESP (12), NT 10-K (11), UPLOAD (9)1
    All 20 form types

    4 (6), 10-Q/A (3), 3 (3), EFFECT (2), NT 10-Q/A (2), S-1 (2), SC 13G (2), 10-K/A (1), NTN 10K (1), POS AM (1), RW (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-K) May 29, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Latest 8-K (8-K) Apr 14, 2025

Risk factors and legal proceedings

Legal proceedings

On August 6, 2019, the former CEO (prior to the Company’s bankruptcy proceedings) filed a lawsuit against the Company’s subsidiary, Stemtech Health Sciences Corp., alleging unpaid salary and vacation pay related to a period prior to the current management team assuming control in 2018. The total claim is for approximately $267,000. The Company has filed a counterclaim against the former CEO and considers his claims to be without merit.

As of December 31, 2025, and 2024, the Company has accrued $267,000 related to this matter, which is included in accounts payable and accrued liabilities in the consolidated balance sheets. The Court dismissed the former CEO’s request for summary judgment on March 3, 2023; however, the litigation remains ongoing.

As of the date of this filing, the Company was in default under certain Merchant Cash Advance (“MCA”) financing agreements. The lenders may proceed with legal proceedings seeking recovery of outstanding balances. These balances continue to be fully reflected as liabilities within the Company’s condensed consolidated balance sheet as of December 31, 2025.

The opening of Item 3, Legal Proceedings.24

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24